Reprospher 100 CN-DE

Double-Endcapped Cyano Column for Enhanced Selectivity and Peak Symmetry

Reprospher 100 CN-DE is a cyano-modified HPLC column from Dr. Maisch HPLC GmbH, based on high-purity, fully porous silica with a 100 Å pore size. The phase combines cyanopropyl bonding with an advanced endcapping to reduce silanol activity and improve peak shape — especially for basic and polar analytes. Offering moderate hydrophobicity and strong dipole interaction, this column supports both reversed-phase and normal-phase separations with enhanced stability and reproducibility. It is ideal for method development when orthogonal selectivity or controlled polar interactions are needed.

Reprospher 100 CN-DE from Dr. Maisch HPLC GmbH offers flexible chromatographic performance with enhanced peak shape – ideal for reversed- and normal-phase separations involving polar, ionizable, or structurally related compounds.

Key Features:

  • Cyano bonded phase with deactivated surface – USP L10

  • Dual-mode use: reversed-phase and normal-phase HPLC

  • Fully porous silica with 100 Å pore size

  • Reduced silanol activity for improved peak symmetry

  • Available in 1.7 µm, 1.8 µm, 5 µm, and 10 µm particle sizes

Typical Applications:

  • Polar drugs, isomers, and aromatic compounds

  • Method development requiring moderate retention and orthogonal selectivity

  • Normal-phase chromatography of neutral and polar analytes

  • LC workflows requiring reduced peak tailing for polar species

Specifications

Request Product
Particle Sizes
  • 1.7 µm
  • 1.8 µm
  • 5 µm
  • 10 µm
Pore Size 100 Å
Surface Area 350 m²/g
Phase/Modification CN
Particle Type
Separation Modes
USP Code
Endcapping Yes
Carbonload 7 %
pH Range 2 to 8

Material Numbers

Phase Material Number
Reprospher 100 CN-DE, 1.7 µm rs117.cde.
Reprospher 100 CN-DE, 1.8 µm rs118.cde.
Reprospher 100 CN-DE, 5 µm rs15.cde.
Reprospher 100 CN-DE, 10 µm rs10.cde.
Reprospher 100 CN Reprospher 100 Diol

Any questions?
We are here to help you.

info@dr-maisch.com +49 7073 5035 7

Follow us